Abstract:Abstract Background The resistance to radiationtherapy is responsible for the poor prognosis of ESCC(esophageal squamous cell carcinoma). Our previous clinical study confirmed that YAP1 gene amplification is one of the poor prognostic indicators of radical chemoradiotherapy for ESCC. However, the underlying mechanism by which YAP1 mediates radio-resistance still remained poorly understood. Here we aim to explore the combined guiding value and related action mechanism of YAP1 and its downstream target gene Dickkopf-related protein 1(DKK1) in the treatment of ESCC. Methods We collected the clinical information and tissues of 94 ESCC patients and histodochemistry and survival analysis were performed.Using Western, co-IP, CHIP and luciferase experiments to verify the expression and regulatory relationship of YAP1 and DKK1. We also performed cell viability, transwell, Immunofluorescence of γ-H2AX and clonogenic assay to investigate the proliferation capacity and radiation sensitivity of KYSE510 cells and KYSE150 cells after lentiviral-transfected cell lines were constructed. Finally, Tumor growth curves of mices were used to verify the relationship between cell viability and radiation sensitivity. Results Cell experiments demonstrated that YAP1 overexpression promoted the malignant phenotype of ESCC cells and DNA damage repair to mediate radioresistance. In our present study, YAP1 and DKK1 were firstly found to have a synergistic predictive value for ESCC prognosis. Both knockdown YAP1 and application of YAP1 inhibitor repressed transcriptional activation of DKK1. The CHIP experiment and luciferase reporter showed that YAP1 activated DKK1 directly through its transcription factor TEAD4, which both affected the proliferation and migration ability of esophageal cancer cells. Moreover, the application of the YAP1 inhibitor CA3 combined with X-rays could significantly suppressed the xenograft tumor formation. Conclusion In conclusion, our study uncovers the role and mechanisms through which YAP1 and DKK1 as key regulators of radiotherapy resitance. YAP1/TEAD4 directly regulated the expression of DKK1, both participated in cell radioresistance, proliferation, migration and invasion and may be a potential joint predictor of ESCC.

YAP1-TEAD4-DKK1 is an effective target for inhibiting radiation resistance in esophageal squamous carcinoma and activation of the pathway may be related to poor prognosis of patients

Overexpression of YAP confers radioresistance to esophageal cancer by altering the tumor microenvironment

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.

Supplementary Data from YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer – Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer

YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway

Radiation-induced YAP/TEAD4 binding confers non-small cell lung cancer radioresistance via promoting NRP1 transcription

Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas

The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer

Supplementary Figure 1 from YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer – Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer

The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1)

DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway

Yes-associated Protein (YAP) Predicts Poor Prognosis and Regulates Progression of Esophageal Squamous Cell Cancer Through Epithelial-Mesenchymal Transition.

A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma

YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells

Pathway-Based Analysis Revealed the Role of Keap1-Nrf2 Pathway and PI3K-Akt Pathway in Chinese Esophageal Squamous Cell Carcinoma Patients With Definitive Chemoradiotherapy

Yap Promotes Malignant Progression of Lkb1-Deficient Lung Adenocarcinoma Through Downstream Regulation of Survivin

YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.

Clinical Significance of YAP1 and TAZ in Esophageal Squamous Cell Carcinoma

Gli1 Interacts with YAP1 to Promote Tumorigenesis in Esophageal Squamous Cell Carcinoma.

Elevated HNF1A expression promotes radiation-resistance via driving PI3K/AKT signaling pathway in esophageal squamous cell carcinoma cells

AXL activates YAP through the EGFR-LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma